Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-13-045503
Filing Date
2013-09-24
Accepted
2013-09-24 18:13:36
Documents
2
Period of Report
2013-09-24

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3305
2 POA DOCUMENT poa.txt EX-24.3_488733 3466
  Complete submission text file 0001209191-13-045503.txt   8172
Mailing Address 12555 HIGH BLUFF DRIVE SUITE 385 San Diego CA 92130
Business Address 12555 HIGH BLUFF DRIVE SUITE 385 San Diego CA 92130 (760) 487-1255
Evoke Pharma Inc (Issuer) CIK: 0001403708 (see all company filings)

EIN.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O EVOKE PHARMA, INC. 12555 HIGH BLUFF DR SUITE 385 SAN DIEGO CA 92130
Business Address
D'Onofrio Matthew J (Reporting) CIK: 0001578770 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36075 | Film No.: 131113027